{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:41:55Z","timestamp":1760233315237,"version":"build-2065373602"},"reference-count":29,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Medical Research Council (NMRC)","award":["COVID-19RF-007"],"award-info":[{"award-number":["COVID-19RF-007"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Several human monoclonal Abs for treating Influenza have been evaluated in clinical trials with limited success despite demonstrating superiority in preclinical animal models including mice. To conduct efficacy studies in mice, human monoclonal Abs are genetically engineered to contain mouse heavy chain constant domain to facilitate the engagement of Fc-receptors on mouse immune effector cells. Although studies have consistently reported discrepancies in Ab effectiveness following genetic engineering, the structural and mechanistic basis for these inconsistencies remain uncharacterized. Here, we use homology modeling to predict variable region (VR) analogous monoclonal Abs possessing human IgG1, mouse IgG1, and mouse IgG2a heavy chain constant domains. We then examine predicted 3D structures for variations in the spatial location and orientation of corresponding paratope amino acid residues. By structurally aligning crystal structures of Fabs in complex with hemagglutinin (HA), we show that corresponding paratope amino acid residues for VR-analogous human IgG1, mouse IgG1, and mouse IgG2a monoclonal Abs interact differentially with HA suggesting that their epitopes might not be identical. To demonstrate that variations in the paratope 3D fine architecture have implications for Ab specificity and effectiveness, we genetically engineered VR-analogous human IgG1, human IgG4, mouse IgG1, and mouse IgG2a monoclonal Abs and explored their specificity and effectiveness in protecting MDCK cells from infection by pandemic H1N1 and H3N2 Influenza viruses. We found that VR-analogous monoclonal Abs placed on mouse heavy chain constant domains were more efficacious at protecting MDCK cells from Influenza virus infection relative to those on human heavy chain constant domains. Interestingly, mouse but not human heavy chain constant domains increased target breadth in some monoclonal Abs. These data suggest that heavy chain constant domain sequences play a role in shaping Ab repertoires that go beyond class or sub-class differences in immune effector recruitment. This represents a facet of Ab biology that can potentially be exploited to improve the scope and utilization of current therapeutic or prophylactic candidates for influenza.<\/jats:p>","DOI":"10.3390\/pathogens12010051","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T02:56:50Z","timestamp":1672282610000},"page":"51","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Switching Heavy Chain Constant Domains Denatures the Paratope 3D Architecture of Influenza Monoclonal Antibodies"],"prefix":"10.3390","volume":"12","author":[{"given":"Moffat M.","family":"Malisheni","sequence":"first","affiliation":[{"name":"Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore 138673, Singapore"},{"name":"Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore"},{"name":"Immunology Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117456, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Shoong","family":"Chong","sequence":"additional","affiliation":[{"name":"Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Singapore 138671, Singapore"},{"name":"Integrative Sciences and Engineering Programme, National University of Singapore Graduate School, National University of Singapore, Singapore 119077, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanusya M.","family":"Murali","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore"},{"name":"Immunology Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117456, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiren","family":"Purushotorman","sequence":"additional","affiliation":[{"name":"Immunology Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117456, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinlei","family":"Qian","sequence":"additional","affiliation":[{"name":"Immunology Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117456, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"Laiman","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore"},{"name":"Immunology Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117456, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2278-4497","authenticated-orcid":false,"given":"Yee-Joo","family":"Tan","sequence":"additional","affiliation":[{"name":"Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore 138673, Singapore"},{"name":"Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore"},{"name":"Infectious Diseases Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"MacAry","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore"},{"name":"Immunology Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117456, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Kim, Y.H., Hong, K.J., Kim, H., and Nam, J.H. (2022). Influenza vaccines: Past, present, and future. Reviews in Medical Virology, John Wiley and Sons Ltd.","DOI":"10.1002\/rmv.2243"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/irv.12963","article-title":"The economic burden of influenza among adults aged 18 to 64: A systematic literature review","volume":"16","author":"Cadarette","year":"2022","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/s41467-021-21954-2","article-title":"A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies","volume":"12","author":"Creanga","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/irv.12446","article-title":"Influenza antivirals currently in late-phase clinical trial","volume":"11","author":"Koszalka","year":"2017","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require FcR interactions for protection against influenza virus in vivo","volume":"20","author":"Dilillo","year":"2014","journal-title":"Nat. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2016.05.073","article-title":"Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes","volume":"166","author":"Kallewaard","year":"2016","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"10890","DOI":"10.1073\/pnas.1502374112","article-title":"A broadly neutralizing human monoclonal antibody is effective against H7N9","volume":"112","author":"Tharakaraman","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chom.2016.05.014","article-title":"Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection","volume":"19","author":"Leon","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e01603","DOI":"10.1128\/JVI.01603-17","article-title":"In Vitro Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice","volume":"91","author":"Sutton","year":"2017","journal-title":"J. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fmicb.2016.00022","article-title":"Ig constant region effects on variable region structure and function","volume":"7","author":"Janda","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1080\/19420862.2017.1367074","article-title":"IgG cooperativity\u2013Is there allostery? Implications for antibody functions and therapeutic antibody development","volume":"9","author":"Yang","year":"2017","journal-title":"mAbs"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"108856","DOI":"10.1016\/j.celrep.2021.108856","article-title":"A compact vocabulary of paratope-epitope interactions enables predictability of antibody-antigen binding","volume":"34","author":"Akbar","year":"2021","journal-title":"Cell Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/19420862.2017.1323159","article-title":"Affinity of human IgG subclasses to mouse Fc gamma receptors","volume":"9","author":"Dekkers","year":"2017","journal-title":"MAbs"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/j.1460-2075.1986.tb04288.x","article-title":"The relation between the divergence of sequence and structure in proteins","volume":"5","author":"Chothial","year":"1986","journal-title":"EMBO J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-60761-842-3_6","article-title":"Template-based protein structure modeling","volume":"673","author":"Fiser","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/prot.22458","article-title":"Structure is three to ten times more conserved than sequence\u2014A study of structural response in protein cores","volume":"77","author":"Ardell","year":"2009","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: Homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1093\/bioinformatics\/btu426","article-title":"YASARA View\u2014Molecular graphics for all devices\u2014From smartphones to workstations","volume":"30","author":"Krieger","year":"2014","journal-title":"Bioinformatics"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/0471250953.bi0506s15","article-title":"Comparative Protein Structure Modeling Using Modeller","volume":"15","author":"Eswar","year":"2006","journal-title":"Curr. Protoc. Bioinform."},{"key":"ref_21","unstructured":"WHO (2022, October 13). Serological Detection of Avian Influenza A(H7N9) Infections by Microneutralization Assay [Internet]. Available online: http:\/\/www.who.int\/influenza\/gisrs_laboratory\/manual_diagnosis_surveillance_influenza\/."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.bpj.2009.11.011","article-title":"Determination of ensemble-average pairwise root mean-square deviation from experimental B-factors","volume":"98","author":"Kuzmanic","year":"2010","journal-title":"Biophys. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1146\/annurev.biochem.66.1.549","article-title":"Protein folding: The endgame","volume":"66","author":"Levitt","year":"1997","journal-title":"Annu. Rev. Biochem."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Malisheni, M.M., Bates, M., Rizvanov, A.A., and MacAry, P.A. (2022). SARS-CoV-2 Antibody Effectiveness Is Influenced by Non-Epitope Mutation\/Binding-Induced Denaturation of the Epitope 3D Architecture. Pathogens, 11.","DOI":"10.3390\/pathogens11121437"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"13737","DOI":"10.1073\/pnas.0907195106","article-title":"Conformational selection or induced fit: A flux description of reaction mechanism","volume":"106","author":"Hammes","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1038\/ncomms4614","article-title":"Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus","volume":"5","author":"Lee","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1126\/science.aaz5143","article-title":"Different genetic barriers for resistance to HA stem antibodies in influenza H3 and H1 viruses","volume":"368","author":"Wu","year":"2020","journal-title":"Science"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"12471","DOI":"10.1128\/JVI.01388-13","article-title":"Antibody Recognition of the Pandemic H1N1 Influenza Virus Hemagglutinin Receptor Binding Site","volume":"87","author":"Hong","year":"2013","journal-title":"J. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.cell.2021.03.029","article-title":"Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein","volume":"184","author":"Suryadevara","year":"2021","journal-title":"Cell"}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/1\/51\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:54:39Z","timestamp":1760147679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/1\/51"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,28]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["pathogens12010051"],"URL":"https:\/\/doi.org\/10.3390\/pathogens12010051","relation":{},"ISSN":["2076-0817"],"issn-type":[{"type":"electronic","value":"2076-0817"}],"subject":[],"published":{"date-parts":[[2022,12,28]]}}}